Your session is about to expire
← Back to Search
Non-invasive Brain Stimulation for Autism
Study Summary
This trial will use tDCS in combination with ABA to see if it can improve the acquisition of educational programs for children with ASD.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a hole or opening in your skull.You are taking medications that affect dopamine, such as drugs for Parkinson's disease or antipsychotic medications.You have had a seizure within the past two years.You are taking medications that block sodium or calcium channels, which includes certain anti-seizure medications., are required
It is necessary to have stable medical and behavioural treatments for at least 4 weeks prior to and during the study.Boys and girls between the ages of 5 and 12 who have autism.You have complete loss of vision or hearing in your peripheral (side) vision or hearing.If you are taking certain medications, you will not be able to participate in the study because they could interfere with the results.You are taking medications or substances that can increase the risk of seizures.You have a history of receiving magnetic or electrical stimulation treatments.The individual was able to wear the tDCS device for a week without any adverse effects.You are taking medications that affect norepinephrine, like propranolol or stimulant drugs.You have a serious brain condition like a traumatic brain injury, brain tumor, or infection inside your brain.You are taking medications that affect the NMDA receptors, like dextromethorphan or cycloserine.You have a current skin condition that is severe or causing discomfort.
- Group 1: Sham tDCS first
- Group 2: Active tDCS first
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this medical trial limited to individuals of a certain age?
"This particular research endeavour requires that its participants are aged between five and twelve years old. The study contains 236 trials for minors, while those over 65 have 52 studies to choose from."
Is participation in this trial still open to new recruits?
"Twenty-four children between the ages of 5 and 12 with a diagnosis of autism spectrum disorder are eligible for this trial. Furthermore, they must be able to wear tdcs after desensitization training, and have had stable treatments in the 4 weeks prior to enrollment."
Is enrollment for this trial still accessible to potential participants?
"Clinicaltrials.gov provides evidence that this medical trial is not currently seeking participants, despite first being posted on November 1st 2021 and last edited a day later. Fortunately, 289 other studies are presently taking in patients."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger